Tepanil (Diethylpropion Hydrochloride) - Indications and Dosage

INDICATIONS AND USAGE

Diethylpropion hydrochloride tablets are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regiment of weight reduction based on caloric restriction. The usefulness of agents of this class should be measured against possible risk factors inherent in their use such as those described (see CLINICAL PHARMACOLOGY).

DOSAGE AND ADMINISTRATION

Diethylpropion hydrochloride 75 mg (controlled release) tablets: One tablet daily, swallowed whole, in mid-morning.

HOW SUPPLIED

Diethylpropion hydrochloride 75 mg tablets are oval, white, domed, imprinted “2690V” on one side and plain on the other.

Diethylpropion hydrochloride 75 mg tablets are supplied in bottles of 100 and 250.

Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Store at controlled room temperature, 15°- 30°C (59°- 86°F).

CAUTION:

Federal law prohibits dispensing without prescription.

Manufactured by:
3M Pharmaceuticals
Northridge, CA 91324

Manufactured for:
Qualitest Products, Inc.

IN99
Rev 2/95
R1